Genoa, Italy

Alessandro Balbi

This inventor holds 1 USPTO granted patent. Top assignee: Carlo Erba. Active years: 1977.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Alessandro Balbi in Depression Treatment

Introduction

Alessandro Balbi is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of depression. His innovative work has led to the development of a unique class of compounds that show promise in addressing mental health issues.

Latest Patents

Alessandro Balbi holds a patent for "1-Oxo-1H-naphtho [2,1-b] pyran derivatives for treating depression." This patent includes compounds such as 1-oxo-3-(N-methyl-N-ethyl) amino-1H-naphtho [2,1-b] pyran. These derivatives are disclosed along with pharmaceutical compositions that utilize them. The method of treating depression involves administering these compositions, which are active on the central nervous system and function as antidepressive agents. Balbi's patent represents a significant advancement in the search for effective treatments for depression.

Career Highlights

Alessandro Balbi is associated with Carlo Erba, a company known for its focus on pharmaceutical innovations. His work at Carlo Erba has allowed him to explore and develop new therapeutic options for mental health treatment. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Balbi has collaborated with notable colleagues, including Aldo Ermili and Norina Passerini. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Alessandro Balbi's contributions to the field of depression treatment through his innovative patents highlight the importance of research in mental health. His work continues to pave the way for new therapeutic options that can improve the lives of those affected by depression.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…